Universitätsklinikum Carl Gustav Carus HOW TO FIND US WELCOME

Saturday, March 17, 2012
HOW TO FIND US
Auditorium in the Dean´s Building (House 40)
Immunoadsorption
09.00 –09.15 T
herapeutische Apheresen in der Transplantationsmedizin
S. Rummler, Jena
09.15 –09.30 Bestimmung von Antikörpern in Eluaten von Immunadsorptionen, gewonnen von Patienten mit humoralen
Abstoßungen nach solider Organtransplantation
D. Barz, Jena
09.30 –09.45 Immunoadsorption in hemophilia
H. Zeitler, Bonn
09.45 –10.00 Ig apheresis for the treatment of severe DCM patients
S. Pokrovski, Moscow
10.00 –10.15 Immunadsorption bei DCM und pulmonaler Hypertonie
M. Dandel, Berlin
10.15 –10.30 Immunoadsorption in steroid refractory multiple sclerosis
M. Koziolek, Göttingen
10.30 –10.45 Immunadsorption bei steroidrefraktärem Schub
der multiplen Sklerose
F. Heigl, Kempten
10.45 –11.00 Break
11.00 –11.15 Erfahrungen mit der Immunadsorption bei Myasthenia gravis
W. Köhler, Wermsdorf
11.15 –11.30 Apheretische Therapie bei sekundärem Raynaudsyndrom
M. Jünger, Greifswald
11.30 –11.45 Immunoadsorption in Buerger´s disease
P. Klein-Weigel, Berlin
11.45 –12.00 Atopische Dermatitis und Immunadsorption
A. Zink, Munich
12.00 –12.15 Erfahrungen in der Behandlung des Pemphigus
mit Immunadsorption
C. Günther, Dresden
12.15 –12.30 Erfahrungen mit Immunadsorption bei Patienten
mit EHEC-HUS
S. Stracke, Greifswald
12.30 –14.00 Break
Lipoprotein apheresis
14.00 –14.15
14.15 –14.30
14.30 –14.45
14.45 –15.00
15.00 –15.30
15.30 –16.00
L ipoprotein apheresis for the CHD patients after CABG
M. Ezov, Moscow
Lipoprotein apheresis for Lp(a) – new data
E. Steinhagen-Thiessen, Berlin
Specific Lp(a) apheresis. Moscow study
M. Safarova, Moscow
Impact of lipoprotein apheresis on Egr-1, c-Jun, c-Fos,
and Hsp70 gene expression in white blood cells
V. Schettler, Göttingen
Lipoproteinapherese – vom Standard zur
individualisierten Behandlung
W. Ramlow, Rostock
How will new medications affect the apheresis situation
in Germany?
K. Parhofer, München
University Clinical Center Dresden
Department of Medicine III
Fetscherstraße 74 · 01307 Dresden
Universitätsklinikum
Carl Gustav Carus
DIE DRESDNER.
2nd Dresden
International
Symposium on
Therapeutic
Apheresis
March 15–17, 2012
Lipidologische
Fortbildung
March 16, 2012
Dear colleague,
this is already the second international symposium on therapeutic
apheresis taking place in Dresden.
The aim is to organize a high level international conference on
apheresis, immunoadsorption for autoimmune diseases, and photopheresis. We hope that the lectures by prominent invited speakers will
spark lively discussions and complete a comprehensive overview on
the potential of apheresis as well as ways to reach therapeutic targets.
For this occasion, it is a pleasure to invite you to the beautiful city
of Dresden, which, after decades of restauration shines anew these
days. In fact, the University Clinical Center is just 15 minutes away
from the very center of the old city. We hope to see you in Dresden.
With best regards
Prof. Dr. Ulrich Julius
REGISTRATION
Please register by sending or faxing the paper attached to the
Carl Gustav Carus Management GmbH.
You can also register via E-mail:
CGCManagementGmbH@uniklinikum-dresden.de
Or write an e-mail to:
ulrich.julius@uniklinikum-dresden.de
The registration fee for participants is 80 EUR up
to March 01, 2012.
Thereafter the registration fee will be 100 EUR
(physicians / scientists in training 40 EUR,
students (with ID) 20 EUR)
The Gala Dinner will be included.
We will apply for CME points at the
Sächsische Landesärztekammer.
Actual information about the symposium including the scientific
program will be provided on the following website:
http://mk3.uniklinikum-dresden.de/apheresissymposium
International Travel
Dresden International airport is approximately
30 minutes from the clinical center and served by
regional railway. International trains arrive both
at Dresden main station and at Dresden Neustadt
with convenient connections to tramway lines.
Public Transport
The University Clinical Center is served by tramway
lines 6 and 12 (Stop: Augsburger Straße/Universitätsklinikum) as well as bus lines 74 and 62 (Stop:
Universitätsklinikum).
Car
For fee parking is available at the Fiedlerstraße
main entrance parking deck with room for 500 cars.
HOW
TO FIND US
WELCOME
Department of Medicine III
University Clinical Center Dresden
Fetscherstr. 74 · 01307 Dresden · Germany
Bank: Deutsche Kreditbank AG
Account No.: 11 248 333 Bank code: 120 300 00
IBAN: DE 71 1203 0000 0011 248 333 BIC: BYLADEM 1001
Thursday, March 15, 2012
Auditorium in the Dean´s Building (House 40)
Lipoprotein apheresis
13.00 –13.30
13.30 –14.00
14.00 –14.20
14.20 –14.40
14.40 –15.00
15.00 –15.20
15.20 –15.40
15.40 –16.00
16.00 –16.20
16.20 –16.40
16.40 –17.00
17.00 –17.20
17.20 –17.40
17.40 –18.00
18.00 –18.20
18.20 –18.40
18.40 –19.00
SC/EAS Guidelines published in September 2011
E
J. Chapman, Paris
Therapeutischer Stellenwert der Lipoproteinapherese
im Wandel der Zeit
P. Schuff-Werner, Rostock
Acute and chronic effects of therapeutic apheresis
A. Rammuni, Bari
Lipid-unrelated effects of lipoprotein apheresis
on vascular protection
C. Steffanutti, Roma
Break
Therapeutic hemapheresis in patients with
refractory dyslipidemias
G. Konovalov, Moscow
Lipoprotein apheresis and HDL
P. Moriarty, Kansas City (USA)
Regular lipoprotein apheresis maintains residual cardiovascular and microvascular function in patients with
advanced atherosclerotic disease
T. Ziemssen, Dresden
Lipoproteinapherese-Standard für Apherese-Kompetenzzentren – eine aktualisierte Synthese und Ergänzung
bereits vorhandener Standards
F. Heigl, Kempten
The decrease of mean platelet volume after
extracorporeal LDL-cholesterol elimination in patients
with severe familial hypercholesterolemia
M. Blaha, Hradec Kralove
Break
Therapeutische Apheresen im Kindes- und Jugendalter,
evidence based, technisch anspruchsvoll?
V. Witt, Vienna
Effects of lipoprotein apheresis on the PCSK9 levels
NN
Immunosorbents for clinical use. State of the art
S. Pokrovsky, Moscow
HELP-Apherese bei Hörsturz
A. Dietz, Leipzig
Actual situation of lipoprotein apheresis in Saxony
U. Julius, Dresden
The evidence – base for the efficacy of lipoprotein
apheresis in combating cardiovascular disease
G. Thompson, London
Friday, March 16, 2012
Friday, March 16, 2012
Friday, March 16, 2012
Auditorium in the Dean´s Building (House 40)
Lecture Hall 1 in the Medizinisch-Theoretischem Zentrum (House 91)
Hörsaal im Dekanatsgebäude, Haus 40 (Medizinische Fakultät Carl Gustav
Carus Dresden); Fiedlerstrasse 27, 01307 Dresden
Immunoadsorption
Lipoprotein apheresis
Lipidologische Fortbildung (in German, free of charge)
09.00 –09.20 P
lasmaaustausch und Immunapherese - Blutungskomplikationen durch Verlust von Fibrinogen
K. Derfler, Vienna
09.20 –09.40 Autoantibodies against structures of the central nervous
system – pathophysiological relevance and perspectives for
immunoadsorption
R. Klingel, Cologne
09.40 –10.00 Immunapherese auf der Intensivstation
M. Meier, Reinbek
10.00 –10.20 Immunoadsorption in patients with autoimmune ion
channel disorders of the PNS
C. Antozzi, Milano
10.20 –10.40 Immunadsorption in der Nierentransplantation
G. Bartel, Vienna
10.40 –11.00 Break
11.00 –11.20 Immunadsorption bei crossmatch positiver
Nierentransplantation
C. Morath, Heidelberg
11.20 –11.40 Rheohemapheresis in the treatment of nonvascular
age-related macular degeneration (impact on drusenoid
retinal pigment epithelium detachment)
M. Blaha, Hradec Kralove
11.40 –12.00 Immunoadsorption in connective tissue
diseases – an update
M. Aringer, Dresden
09.00 –09.20 H
ow to optimize lipoprotein apheresis
treatment – a second look
V. Schettler, Göttingen
09.20 –09.40 Aufgaben von Ärzten bei der Lipoproteinapherese aus
der Sicht des Pflegepersonals
K. Johne, Dresden
09.40 –10.00 Labor bei der Lipoproteinapherese – Was, wann, warum?
A. Ramlow, Rostock
10.00 –10.20 Iron deficit in patients treated by lipoprotein
apheresis and its treatment
U. Schatz, Dresden
10.20 –10.40 Effects of lipoprotein apheresis on the FABP4 levels
V. Zepter, Dresden
10.40 –11.00 Break
11.00 –11.20 Lipidomics in patients treated by lipoprotein apheresis
J. Gräßler, Dresden
11.20 –11.40 Homocystein levels in patients treated with lipoprotein
apheresis – effects of vitamin treatment
S. Tselmin, Dresden
11.40 –12.00 Factors inducing cardiovascular events in patients treated
by lipoprotein apheresis
K. Taseva, Dresden
12.00 –12.20 Differences in the atherogenic risk of patients treated
by lipoprotein apheresis according to their lipid pattern
M. v. Dryander, Dresden
12.20 –12.40 Comparison of performance of whole blood and plasma
lipoprotein apheresis using the Liposorber systems
O. Hequet, Lyon
12.40 –13.10 Is there a future for lipoprotein apheresis after the advent
of Lomitapide and Mipomersen?
C. Stefanutti, Roma
Photopheresis
12.00 –12.20
12.20 –12.40
12.40 –13.00
13.00 –13.20
13.20 –13.40
13.40 –14.00
19.30 xtracorporeal photopheresis: presence and future
E
S. Beissert, Dresden
Extracorporeal photopheresis in the treatment of
acute Graft versus Host Disease
N. Worel, Vienna
Extracorporeal photopheresis in the treatment of
chronic Graft versus Host Disease
K. Hölig, Dresden
Extracorporeal photopheresis in the treatment of
inflammatory bowel disease
W. Reinisch, Vienna
Extracorporeal photopheresis- mechanisms of action
H. Hackstein, Giessen/Marburg
Break
In Zusammenarbeit mit der Lipid-Liga findet eine LipidologieFortbildung statt.
Diese wird von der Prüfungskommission der DGFF für die Weiterbildung im
Rahmen der „strukturierten curriculären Fortbildung Lipidologie der DGFF“
als geeignet anerkannt.
Deutsche Gesellschaft
zur Bekämpfung von
Fettstoffwechselstörungen
und ihren Folgeerkrankungen
DGFF (Lipid-Liga) e. V.
14.00 –16.30
1.Lipidsenkende Therapie mit Statinen, Ezetrol,
Ionenaustauschern und Fibraten
S. Fischer, Dresden
2.Einsatz der Nikotinsäure bei Fettstoffwechselstörungen – aktuelle Datenlage
U. Julius, Dresden
3.Diagnostik und Therapie des
Chylomikronämie-Syndroms
H.-U. Klör, Giessen
4.Bedeutung und Behandlung von erhöhtem
Lipoprotein(a); Indikationen zur Lipoproteinapherese
H. Berthold, Berlin
5.Lipidtherapie – heute und morgen
E. Windler, Hamburg
ALA DINNER (included)
G
Restaurant “Italienisches Dörfchen”
Theaterplatz 3, 01067 Dresden
Scientific Program supported by: • Fresenius Medical Care GmbH • Kaneka Pharma Europe N.V. • Miltenyi Biotec GmbH • B. Braun Melsungen AG • DIAMED Medizintechnik GmbH • medicap clinic GmbH • Trommsdorff GmbH & Co. KG Arzneimittel • MSD SHARP & DOHME GMBH • Genzyme GmbH
• Vifor Pharma Deutschland GmbH • AstraZeneca Deutschland GmbH • Roche Deutschland Holding GmbH